Page 4 - Largest Japanese (NIKKEI) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Nov 20, 2024

Discover large cap Japanese Pharmaceuticals & Biotech companies that are on the NIKKEI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

90 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

130A

Veritas In Silico
JP¥905.000.6%n/aJP¥5.8bn/an/an/an/a

4539

Nippon Chemiphar
JP¥1,514.002.0%-7.6%JP¥5.5bn/aPB0.3xn/a3.3%

4584

Kidswell Bio
JP¥118.006.3%-23.9%JP¥4.8bJP¥450.00n/aE48.1%n/a

2397

DNA Chip Research
JP¥702.00-1.3%-1.8%JP¥4.8bn/aPS6.2xn/an/a

4570

Immuno-Biological Laboratories
JP¥501.002.9%-8.7%JP¥4.7bn/aPE20.2xn/a0%

4881

FunPep
JP¥145.0010.7%-9.4%JP¥4.6bn/aPB2.2xn/an/a

4594

BrightPath Biotherapeutics
JP¥54.008.0%-45.5%JP¥4.5bn/an/an/an/a

4586

MedRx
JP¥93.002.2%-42.6%JP¥4.4bn/aPS17.1xn/an/a

4598

Delta-Fly Pharma
JP¥523.00-23.0%-57.2%JP¥4.3bn/aPB5.9xn/an/a

4576

D. Western Therapeutics Institute
JP¥104.0050.7%-36.6%JP¥3.9bn/aPS8.5xn/an/a

4892

Cyfuse Biomedical K.K
JP¥484.00-10.4%-40.6%JP¥3.8bn/aPS62.6xn/an/a

4889

Renascience
JP¥284.00-0.7%-38.7%JP¥3.6bn/aPS25.6xn/an/a

6090

Human Metabolome Technologies
JP¥604.001.7%-10.1%JP¥3.6bn/aPE14.5xn/a2.5%

4596

Kubota Pharmaceutical Holdings
JP¥61.003.4%-20.8%JP¥3.4bn/aPS111xn/an/a

4591

Ribomic
JP¥83.003.8%-30.3%JP¥3.4bn/aPS1686.7xn/an/a

2342

Transgenic Group
JP¥203.00-2.4%-19.8%JP¥3.4bn/aPB0.6xn/a1.5%

4241

atect
JP¥460.00-1.7%-30.0%JP¥2.0bn/aPB1.2xn/a2.2%

6190

PhoenixBio
JP¥358.00-10.5%-25.1%JP¥1.5bn/aPE207.5xn/an/a
Page 4 of 4
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.